Myeloblasts from Down syndrome children with acute myeloid leukemia have increased in vitro sensitivity to cytosine arabinoside and daunorubicin.
Taub
J W
JW
Stout
M L
ML
Buck
S A
SA
Huang
X
X
Vega
R A
RA
Becton
D L
DL
Ravindranath
Y
Y
D000208:Acute Disease; D001853:Bone Marrow / Q000187:drug effects; D002470:Cell Survival / Q000187:drug effects; D002648:Child; D003561:Cytarabine / Q000627:therapeutic use*; D003630:Daunorubicin / Q000627:therapeutic use*; D004314:Down Syndrome / Q000150:complications / Q000473:pathology*; D006801:Humans; D007951:Leukemia, Myeloid / Q000150:complications / Q000188:drug therapy*; D014407:Tumor Cells, Cultured / Q000187:drug effects
D003561:Cytarabine; D003630:Daunorubicin